Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for SOPHiA GENETICS (SOPH) over the last 5 years, with Q3 2025 value amounting to 0.52%.

  • SOPHiA GENETICS's Return on Capital Employed fell 600.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.43% for FY2024, which is 400.0% down from last year.
  • As of Q3 2025, SOPHiA GENETICS's Return on Capital Employed stood at 0.52%, which was down 600.0% from 0.53% recorded in Q2 2025.
  • SOPHiA GENETICS's Return on Capital Employed's 5-year high stood at 0.24% during Q4 2021, with a 5-year trough of 0.53% in Q2 2025.
  • For the 5-year period, SOPHiA GENETICS's Return on Capital Employed averaged around 0.41%, with its median value being 0.4% (2022).
  • In the last 5 years, SOPHiA GENETICS's Return on Capital Employed plummeted by -1600bps in 2022 and then surged by 200bps in 2023.
  • Over the past 5 years, SOPHiA GENETICS's Return on Capital Employed (Quarter) stood at 0.24% in 2021, then plummeted by -67bps to 0.4% in 2022, then dropped by -10bps to 0.44% in 2023, then decreased by -9bps to 0.48% in 2024, then fell by -10bps to 0.52% in 2025.
  • Its Return on Capital Employed stands at 0.52% for Q3 2025, versus 0.53% for Q2 2025 and 0.52% for Q1 2025.